Blauvelt, A.; Leonardi, C.; Zachariae, C.; Burge, R.; Ridenour, T.; McKean-Matthews, M.; Garces, S.; Cameron, G. Efficacy, Health-Related Outcomes, and Safety of Ixekizumamb for up to Five Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis. J of Skin 2017, 1, s12.